Recruiting

4

400

RoW

low-dose aspirin, conventional-does aspirin

Xijing Hospital, Shaanxi Provincial People's Hospital, The First Affiliated Hospital of Jiaotong University, Tang-Du Hospital, The First Affiliated Hospital of Xi'an Medical University, Xi'an Central Hospital, Xiangyang Central Hospital, Baoji Central Hospital

Ischemic Stroke

02/22

08/22

Recruiting

4

364

RoW

Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult, Pseudomonas Aeruginosa Infection

10/25

12/25

Completed

3

620

RoW

GLP-1 receptor agonist, Placebo, PB-119 Placebo

PegBio Co., Ltd.

Type 2 Diabetes Mellitus (T2DM)

09/22

05/23

Recruiting

3

204

RoW

Solriamfetol, Placebo

Ignis Therapeutics (Suzhou) Limited

Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea

09/24

10/24

Recruiting

3

1500

Europe, RoW

Donanemab, (LY3002813), Placebo

Eli Lilly and Company

Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

04/27

04/27

Recruiting

2a

60

RoW

50561 high dose, 50561 low dose, Placebo

Beijing Joekai Biotechnology LLC

Alzheimer's Disease

05/24

06/24

Active, not recruiting

2

196

RoW

TCM Formula, RSYR decoction, Placebo, Placebo dicoction

Peking University Cancer Hospital & Institute

Cancer-related Problem/Condition

09/23

06/24

Recruiting

2

260

RoW

Placebo group, JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 low-dose group, JS1-1-01 pills; JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 pills; JS1-1-01 placebo pills, JS1-1-01 high-dose group, JS1-1-01 pills; Duloxetine hydrochloride placebo capsules, Active drug group, JS1-1-01 placebo pills; Duloxetine hydrochloride enteric coated capsule

Tasly Pharmaceutical Group Co., Ltd

Depression

04/25

04/25

Not yet recruiting

2

46

RoW

Relmacabtagene Autoleucel, JWCAR029, Fludarabine, Cyclophosphamide

Shanghai Ming Ju Biotechnology Co., Ltd.

Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma, Mediastinal B-Cell Diffuse Large Cell Lymphoma

08/24

02/27

Recruiting

1/2

100

RoW

Chidamide, epidaza, Cyclophosphamide, Epirubicin, Vindesine, Etoposide, Prednisone

Peking Union Medical College Hospital, Chinese PLA General Hospital, Peking University First Hospital, Peking University Third Hospital, Peking University Cancer Hospital & Institute, Tianjin Medical University Cancer Institute and Hospital

T Cell Non-Hodgkin's Lymphoma

03/20

03/23

Recruiting

1/2

46

RoW

Tislelizumab combined with Liposomal mitoxantrone hydrochloride, Maintenance of tislelizumab

Sun Yat-sen University

Extranodal Natural Killer T Cell Lymphoma

01/24

01/25

Completed

1

62

RoW

Jiedu Yizhi Formula, Donepezil Hydrochloride Tablets

Changchun University of Chinese Medicine

Ensure the Legality and Compliance of the Testing Process

12/23

04/24

Recruiting

1

10

RoW

Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes., Autologous Tris-CAR-T cell.

Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Tasly Pharmaceutical Group Co., Ltd

Recurrent Glioblastoma

11/24

11/32

Active, not recruiting

N/A

3637

RoW

Changhai Hospital, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 904 Hospital of the PLA Joint Logistics Support Force, Gongli Hospital, Yueyang Hospital, Shanghai University of Traditional Chinese medicine

Coronary Arteriosclerosis

06/21

12/30

Active, not recruiting

N/A

3000

RoW

Changhai Hospital, Yueyang Hospital, Shanghai University of Traditional Chinese medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 904 Hospital of the PLA Joint Logistics Support Force, Gongli Hospital

Coronary Artery Disease, Carotid Plaque

03/22

12/30

Recruiting

N/A

10254

RoW

Limeng Chen

Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder

12/24

12/24

Not yet recruiting

N/A

280

RoW

Methacholine Chloride

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Asthma

02/23

06/23

Recruiting

N/A

146

RoW

Acupuncture, basic therapy

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

Acupuncture, Covid-19 Omicron, Pulmonary Function

04/23

04/23

Recruiting

N/A

159

RoW

electroacupuncture, acupuncture

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

Erectile Dysfunction, Acupuncture Therapy, Median Nerve Disease

12/23

12/23

Recruiting

N/A

60

RoW

Changhai Hospital

Explore the Consistency of Drug Sensitivity Between Primary Colorectal Cancer and Liver Metastases

12/23

12/24

Recruiting

N/A

20

RoW

[18F]AlF-NOTA-pentixather PET/CT, pathological examination

Sichuan Provincial People's Hospital

Aldosterone-Producing Adenoma

01/24

06/24

Recruiting

N/A

90

RoW

disc resection, segmental resection

Fudan University

Gastrointestinal Function, Quality of Life, Pregnancy Outcomes

12/24

12/24

Recruiting

N/A

570

RoW

Stent-based Diverting Technique

Sir Run Run Shaw Hospital

Rectal Neoplasms

12/24

06/25

Not yet recruiting

N/A

80

NA

Tilted Gaze Target Tast, Conventional Examination Methods

Tianjin Eye Hospital

Children With Torticollis

06/24

12/24

Active, not recruiting

N/A

10560

RoW

ctDNA methylation analysis by NGS

AnchorDx Medical Co., Ltd., Xiangya Hospital of Central South University, West China Hospital, Shanghai Zhongshan Hospital, Shanghai Pulmonary Hospital affiliated to Tongji University, First Hospital of China Medical University, Guizhou Provincial People's Hospital, Shanghai Chest Hospital, First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital Xi'an Jiaotong University, Qilu Hospital of Shandong University, Inner Mongolia People's Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Zhengzhou University, Second Hospital of Jilin University, LanZhou University, Peking University Third Hospital, The First People's Hospital of Yunnan, Shantou Affiliated Hospital of Sun Yat-Sen University, Ruijin Hospital, The Shanghai Jiao Tong University Medical School, Tongji Hospital, The First Affiliated Hospital of Guangzhou Medical University, Xijing Hospital, Air Force Medical University of PLA, Shenzhen People's Hospital, Henan Provincial People's Hospital, Beijing Chao Yang Hospital, Xiamen Second Hospital, The First Affiliated Hospital of Nanchang University

Pulmonary Nodules

09/24

06/25

Not yet recruiting

N/A

1000

RoW

Continuous Glucose Monitoring System (GX-01S)

Nanjing First Hospital, Nanjing Medical University

Type1 Diabetes Mellitus

10/26

06/27

Not yet recruiting

N/A

120

RoW

Angong Niuhuang Pill (ANP), Control (Standard treatment)

Nanjing Medical University, The First Affiliated Hospital with Nanjing Medical University, Beijing Anzhen Hospital, Capital Medicine University

Cardio-pulmonary Bypass, Cardiovascular Surgery, Cerebral Protection, Brain Injury

12/25

12/25

Recruiting

N/A

300

RoW

Follow up

Fujian Maternity and Child Health Hospital

Cervical Intraepithelial Neoplasia, HPV Infection, Virus Integration, HSIL, High Grade Squamous Intraepithelial Lesions

12/25

05/26

Recruiting

N/A

46

RoW

Additional hCG injection, estrogen and dydrogesterone

Fudan University

Luteal Phase Deficiency, Luteal Phase Support, Idiopathic Hypogonadotropic Hypogonadism

12/25

12/25

Recruiting

N/A

100000

RoW

Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital

Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia

01/38

01/38

Active, not recruiting

N/A

3000

RoW

Changhai Hospital, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 904 Hospital of the PLA Joint Logistics Support Force, Gongli Hospital, Yueyang Hospital, Shanghai University of Traditional Chinese medicine

Coronary Artery Disease

12/21

12/30

Recruiting

4

120

RoW

RDD, RDD group, VDD, VDD group

Shandong Provincial Hospital

Hematologic Neoplasms, Multiple Myeloma, Efficacy, Safety

12/21

12/22

Recruiting

4

230

RoW

Micafungin Sodium

Shandong Provincial Hospital

Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease

01/23

10/23

Recruiting

3

2

RoW

SIB-IMRT, Paclitaxel, Platinum-Based Drug, Involved Field Irradiation (IFI)

Chinese Academy of Medical Sciences

IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer

08/21

12/22

Recruiting

3

100

RoW

Azacitidine combined HHT, Azacitidine+HHT, Azacitidine regimen, Azacitidine group

Shandong Provincial Hospital

Myelodysplastic Syndromes,Acute Myeloid Leukemia

06/22

12/22

Recruiting

3

130

RoW

Orelabrutinib+R-CHOP; Orelabrutinib+R-DA-EPOCH; Orelabrutinib+R-HD MTX;Orelabrutinib+R+other chemotherapies

Shandong Provincial Hospital

High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, B-cell NonHodgkin Lymphoma

12/23

12/24

Recruiting

3

150

RoW

Orelabrutinib + R-CHOP, ICP-022+ R-CHOP, Placebo + R-CHOP

Beijing InnoCare Pharma Tech Co., Ltd.

Diffuse Large B Cell Lymphoma (DLBCL)

07/24

12/25

Recruiting

3

356

RoW

Orelabrutinib and R-CHOP, R-CHOP

Beijing InnoCare Pharma Tech Co., Ltd.

Treatment-naїve Mantle Cell Lymphoma

12/24

12/27

Recruiting

3

2000

RoW

Radiotherapy, Platinum based chemotherapy, Paclitaxel based chemotherapy, Immunotherapy, 5-FU Analog based chemotherapy, Nimotuzumab

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation, Targeted Therapy, Immunotherapy, Chemotherapy Effect

12/25

12/25

Completed

2

55

RoW

Radiotherapy, Nimotuzumab, S-1

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Esophageal Cancer, Chemoradiotherapy, Nimotuzumab, Unresectable Malignant Neoplasm

12/22

06/23

Recruiting

2

84

RoW

Stereotactic body radiation therapy, SBRT, Anti-PD-1 antibody drug named Sintilimab

West China Hospital

Stage IV HCC, Immunotherapy, SBRT

07/22

07/23

Recruiting

2

55

RoW

Nimotuzumab with chemoradiotherapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Esophageal Cancer, Nimotuzumab, Chemoradiotherapy, Chemotherapy, Immunotherapy

12/25

12/26

Recruiting

2

35

RoW

PD-1 antibody, Chemoradiation, Albumin-Bound Paclitaxel, Cisplatin

Chinese Academy of Medical Sciences

Esophagus Cancer, Chemoradiotherapy, Oligometastatic Disease, Immunotherapy

09/23

09/23

Recruiting

2

186

RoW

Long-course chemoradiation, with or without Tislelizumab (PD-1 inhibitor)

Beijing Friendship Hospital, Beijing Chao Yang Hospital, Xuanwu Hospital, Beijing, Beijing Hospital, Peking Union Medical College Hospital, Peking University First Hospital, Peking University People's Hospital, Peking University Cancer Hospital & Institute, BeiGene

Locally Advanced Rectal Cancer

03/24

09/29

Recruiting

2

90

RoW

Tislelizumab (BGB-A317) with chemoradiotherapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Esophagus Cancer

12/26

12/27

Recruiting

2

20

RoW

Camrelizumab, cisplatin

Henan Cancer Hospital

Squamous Cell Carcinoma of the Skin

07/24

07/24

Recruiting

2

36

RoW

RC48-ADC, Disitamab Vedotin, AK104, Cadonilimab Injection

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Shanxi Province Cancer Hospital

Muscle Invasive Bladder Carcinoma

08/24

08/25

Recruiting

2

60

RoW

stereotactic body radiotherapy

West China Hospital

Prostate Cancer, Stereotactic Body Radiotherapy, High-risk, Efficacy, Safety

06/25

06/25

Recruiting

2

78

RoW

Zanubrutinib, BTK inhibitors, Rituximab, MabThera, Cyclophosphamide, CTX, Doxorubicin, ADM, Vincristine, VCR, Prednisone, Prednisonum

The First Affiliated Hospital of Soochow University

Non-GCB/ABC Diffuse Large B-Cell Lymphoma

10/25

10/25

Recruiting

1/2

170

RoW

Lenvatinib + Envafolimab, Sunitinib

3D Medicines (Sichuan) Co., Ltd.

Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma

12/24

12/24